Biotech
Emerging Pharmas and CROs need each other
Monday, September 14th, 2009
Article authored by David Levin, Vice President at Clinipace. Strategic relationships with CROs have typically been the exclusive domain of large biotechnology and pharmaceutical firms with multi-millions to spend on clinical trials
Read the full story
52 Perspectives: Career Outlook for Pharma & Biotech
Tuesday, September 8th, 2009
With the pharma & biotech job market still in turmoil, we invited Jeff Schwartzman (a Partner at Laguna Source) to share his thoughts on the current state of affairs in the job search and shares his insights on where he things are at, and more importantly his advice on what candidates can do to land a job. 1) Despite
Read the full story
The Economy, Patent Cliffs and Funding¦What™s a Pharmaco to do?
Wednesday, August 26th, 2009
This week’s submission of ’52 Perspectives’ comes to us from Kurt Vorheis, Principal at V2 Bio-Consulting, Inc., a specialized consulting business providing operational expertise to BioPharma, Chemical, and Industrial companies. 1. Given the current state of the economy, what steps do you think are necessary for pharmaceutical companies to take with regard to outsourcing?
Read the full story
Contract Research on the Rise
Tuesday, August 11th, 2009
Reprint from the Scientist magazine. The global economic crisis has got most businesses pinching pennies just to stay afloat, and the drug development industry is no exception. But at least one area of the biotechnology sector — contract research organizations (CROs) — is on the rise
Read the full story
Business Week – Drug Marketing
Business Week – Pharma Marketing
Cafe Pharma
Clinical Trials.gov
FDA on Twitter
Pharma Live
Pharma Voice